Weller J, Katzendobler S, Niedermeyer S, Harter PN, et al. Treatment benefit in patients aged 80 years or older with biopsy-proven and non-resected glioblastoma is dependent on MGMT promoter methylation status. J Neurooncol 2023 Jun 8. doi: 10.1007/s11060-023-04362.
PMID: 37289281